Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kent Teague

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Brain, Behavior, and Immunity|May 30, 2021
Impact of ibuprofen and peroxisome proliferator-activated receptor gamma on emotion-related neural activation: A randomized, placebo-controlled trialKelly T Cosgrove, Rayus Kuplicki, Jonathan Savitz, et al.
Annals of the New York Academy of Sciences|January 23, 2003
Stronger correlation of bcl-3 than bcl-2, bcl-xL, costimulation, or antioxidants with adjuvant-induced T cell survivalThomas C Mitchell, T Kent Teague, David A Hildeman, et al.
Human Immunology|January 16, 2010
Differential IL-7 responses in developing human thymocytesJulie H Marino, Chibing Tan, Ashlee A Taylor, et al.
Brain, Behavior, and Immunity|February 18, 2015
Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorderJonathan Savitz, Wayne C Drevets, Brent E Wurfel, et al.
Brain, Behavior, and Immunity|July 19, 2022
C-Reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorderHaixia Zheng, T Kent Teague, Fang-Cheng Yeh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 31, 2014
Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorderJonathan Savitz, Wayne C Drevets, Chelsey M Smith, et al.
Frontiers in Psychiatry|July 5, 2021
Common Data Elements, Scalable Data Management Infrastructure, and Analytics Workflows for Large-Scale Neuroimaging StudiesRayus Kuplicki, James Touthang, Obada Al Zoubi, et al.
Brain, Behavior, and Immunity|June 25, 2017
Altered populations of natural killer cells, cytotoxic T lymphocytes, and regulatory T cells in major depressive disorder: Association with sleep disturbanceHideo Suzuki, Jonathan Savitz, T Kent Teague, et al.
Psychoneuroendocrinology|December 9, 2014
Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorderJonathan Savitz, Robert Dantzer, Brent E Wurfel, et al.
Neuroimage. Clinical|January 30, 2021
Real-time fMRI neurofeedback amygdala training may influence kynurenine pathway metabolism in major depressive disorderAki Tsuchiyagaito, Jared L Smith, Nour El-Sabbagh, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Brain, Behavior, and Immunity|May 30, 2021
Impact of ibuprofen and peroxisome proliferator-activated receptor gamma on emotion-related neural activation: A randomized, placebo-controlled trialKelly T Cosgrove, Rayus Kuplicki, Jonathan Savitz, et al.
Annals of the New York Academy of Sciences|January 23, 2003
Stronger correlation of bcl-3 than bcl-2, bcl-xL, costimulation, or antioxidants with adjuvant-induced T cell survivalThomas C Mitchell, T Kent Teague, David A Hildeman, et al.
Human Immunology|January 16, 2010
Differential IL-7 responses in developing human thymocytesJulie H Marino, Chibing Tan, Ashlee A Taylor, et al.
Brain, Behavior, and Immunity|February 18, 2015
Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorderJonathan Savitz, Wayne C Drevets, Brent E Wurfel, et al.
Brain, Behavior, and Immunity|July 19, 2022
C-Reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorderHaixia Zheng, T Kent Teague, Fang-Cheng Yeh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 31, 2014
Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorderJonathan Savitz, Wayne C Drevets, Chelsey M Smith, et al.
Frontiers in Psychiatry|July 5, 2021
Common Data Elements, Scalable Data Management Infrastructure, and Analytics Workflows for Large-Scale Neuroimaging StudiesRayus Kuplicki, James Touthang, Obada Al Zoubi, et al.
Brain, Behavior, and Immunity|June 25, 2017
Altered populations of natural killer cells, cytotoxic T lymphocytes, and regulatory T cells in major depressive disorder: Association with sleep disturbanceHideo Suzuki, Jonathan Savitz, T Kent Teague, et al.
Psychoneuroendocrinology|December 9, 2014
Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorderJonathan Savitz, Robert Dantzer, Brent E Wurfel, et al.
Neuroimage. Clinical|January 30, 2021
Real-time fMRI neurofeedback amygdala training may influence kynurenine pathway metabolism in major depressive disorderAki Tsuchiyagaito, Jared L Smith, Nour El-Sabbagh, et al.
Pageof 8